Hepion Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HEPA and other ETFs, options, and stocks.

About HEPA

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. 

CEO
John T. Cavan
CEOJohn T. Cavan
Employees
25
Employees25
Headquarters
Edison, New Jersey
HeadquartersEdison, New Jersey
Founded
2013
Founded2013
Employees
25
Employees25

HEPA Key Statistics

Market cap
9.46M
Market cap9.46M
Price-Earnings ratio
-0.17
Price-Earnings ratio-0.17
Dividend yield
Dividend yield
Average volume
50.76K
Average volume50.76K
High today
High today
Low today
Low today
Open price
$2.07
Open price$2.07
Volume
0.00
Volume0.00
52 Week high
$20.66
52 Week high$20.66
52 Week low
$1.49
52 Week low$1.49
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.